HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hugh G Laverty Selected Research

Prescription Drugs

1/2008Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hugh G Laverty Research Topics

Disease

2Cicatrix (Scar)
09/2011 - 01/2008
1Chemical and Drug Induced Liver Injury
10/2010
1Fibrosis (Cirrhosis)
10/2010
1Inflammation (Inflammations)
10/2010
1Acute Liver Failure (Fulminant Hepatic Failure)
10/2010
1Wounds and Injuries (Trauma)
09/2010

Drug/Important Bio-Agent (IBA)

2human TGFB3 proteinIBA
09/2011 - 09/2010
2Transforming Growth Factor beta (TGF-beta)IBA
09/2011 - 01/2008
1CytokinesIBA
10/2010
1Biomarkers (Surrogate Marker)IBA
10/2010
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2010
1Prescription DrugsIBA
01/2008

Therapy/Procedure

1Therapeutics
09/2011